Devices descending from K042061
7 later devices reach 0.9% Sodium Chloride Injection, Usp BD Postflush SF Flush Syringe through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K121050 | 0.9% Sodium Chloride Injection Usp BD Posiflush Flush Syringe, SF Flush Syringe | Becton, Dickinson & CO | 2013 | 6 | 1 |
| +2 | K153481 | 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe | Becton, Dickinson and Company | 2016 | 1 | 1 |
| +2 | K141311 | 0.9% Sodium Chloride Injection, Usp BD Posiflush; SP Syringe, SF Syringe | Becton, Dickinson and Company | 2014 | 3 | — |
| +3 | K231161 | 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe | Becton, Dickinson and Company | 2023 | 0 | — |
| +3 | K161552 | 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe | Becton, Dickinson and Company | 2017 | 2 | 3 |
| +4 | K250884 | 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe | Becton, Dickinson and Company | 2025 | 0 | — |
| +4 | K213955 | 0.9% Sodium Chloride Injection, USP, BD PosiFlush SafeScrub | Becton, Dickinson and Company | 2022 | 0 | — |